ORAL CONTRACEPTIVE USE FOR REDUCING OVARIAN CANCER RISK SHOULD BE STUDIED FURTHER
Executive Summary
ORAL CONTRACEPTIVE USE FOR REDUCING OVARIAN CANCER RISK SHOULD BE STUDIED FURTHER, a National Institutes of Health consensus conference panel on ovarian cancer screening, treatment and follow-up concluded in a report released April 7.